Author

HARRIS AHMAD 1

1 Bristol Myers Squibb, Princeton, United States

EVALUATION OF OZANIMOD EFFICACY AND SAFETY IN OLDER PATIENTS WITH ULCERATIVE COLITIS: POST HOC ANALYSIS FROM THE PHASE 3 TRUE NORTH STUDY

Peter Irving, Ashwin N. Ananthakrishnan, Irina Blumenstein, Sara Horst, HARRIS AHMAD, Garrett Lawlor, Vanessa Hobbs, Anjali Jain, Arteid Memaj, Nabeel Khan

HISTOLOGICAL INFLAMMATION PREDICTS LOSS OF REMISSION AMONG CROHN'S PATIENTS WITH ENDOSCOPIC REMISSION: A US COHORT ANALYSIS

HARRIS AHMAD

HISTOLOGICAL INFLAMMATION PREDICTS LOSS OF REMISSION AMONG CROHN’S PATIENTS WITH ENDOSCOPIC REMISSION: A US COHORT ANALYSIS

Janet S. Hildebrand, Julie Crawford, HARRIS AHMAD, Jiyoon Choi, Derek Gazis, James Canavan, Benjamin Click, Millie Long

OZANIMOD EFFICACY BY BASELINE ENDOSCOPIC DISEASE DISTRIBUTION IN PATIENTS WITH MODERATE TO SEVERE ULCERATIVE COLITIS: A POST HOC ANALYSIS FROM TRUE NORTH

Axel Dignass, Anita Afzali, Monika Fischer, Charles Sninsky, Alessandro Armuzzi, Chun Wu, HARRIS AHMAD, Arteid Memaj, Sarah Harris, James Canavan, Stefan Schreiber

Item 1 - 4 / 4
1